EP2119459A1 — Treatment of neuropathy involving nitric oxide
Assigned to Nolabs AB · Expires 2009-11-18 · 16y expired
What this patent protects
Nitric oxide is disclosed for use in therapeutic treatment and/or prevention of neuropathy on a target area of a body, wherein said target area comprises skin. Nitric Oxide may be used in a device is provided that allows for target treatment of neuropathy, such as diabetic periph…
USPTO Abstract
Nitric oxide is disclosed for use in therapeutic treatment and/or prevention of neuropathy on a target area of a body, wherein said target area comprises skin. Nitric Oxide may be used in a device is provided that allows for target treatment of neuropathy, such as diabetic peripheral neuropathy.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.